Evaluation of efficacy and toxicity of anthracycline plus cyclophosphamide every three weeks followed by weekly paclitaxel: The Izmır Oncology Group (IZOG) Study
H. Taskaynatan, Y. Cankurtaran, Y. Kucukzeybek, A. Alacacıoğlu, Y. Yildiz, T. Salman, U. Oflazoğlu, U. Varol, Seray Sever, M. Tarhan
{"title":"Evaluation of efficacy and toxicity of anthracycline plus cyclophosphamide every three weeks followed by weekly paclitaxel: The Izmır Oncology Group (IZOG) Study","authors":"H. Taskaynatan, Y. Cankurtaran, Y. Kucukzeybek, A. Alacacıoğlu, Y. Yildiz, T. Salman, U. Oflazoğlu, U. Varol, Seray Sever, M. Tarhan","doi":"10.5505/aot.2019.05668","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"99 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Oncologica Turcica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/aot.2019.05668","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
